Medication Management for Menstrual Cramps

First-Line Treatment: NSAIDs

• The American College of Obstetricians and Gynecologists recommends naproxen sodium 440-550 mg every 12 hours for menstrual cramp relief 1
• Naproxen sodium can be used for perimenstrual prophylaxis, starting 2 days before expected menstruation and continuing for 5 days, as suggested by the American Journal of Obstetrics and Gynecology 2, 3, 4, 5

Treatment Failure Management

• If NSAIDs fail, the Centers for Disease Control and Prevention recommends verifying the diagnosis and considering secondary dysmenorrhea from underlying pelvic pathology, and referring for hormonal contraceptive options or further gynecologic evaluation 6

Important Caveats

• The American Society of Clinical Oncology recommends using the lowest effective dose of NSAIDs for the shortest duration and exercising caution in patients at risk for bleeding or with renal impairment 7

Complementary Non-Pharmacologic Measures

• The American Journal of Obstetrics and Gynecology suggests using heat therapy, such as applying a heating pad or hot water bottle to the abdomen or back, for additional cramping relief 1
• The American Journal of Obstetrics and Gynecology also recommends acupressure, including bilateral stimulation of the Large Intestine-4 (LI4) point and Spleen-6 (SP6) point, for primary dysmenorrhea relief 1

Management of Dysmenorrhea with NSAIDs

Contraindications and Safety Considerations

• The Centers for Disease Control and Prevention recommends using the lowest effective dose for the shortest duration, and exercising caution in patients at risk for bleeding or with renal impairment, as NSAIDs increase adverse effects compared to placebo, including gastrointestinal effects and neurological effects 8, 9
• Contraindications for NSAID use include active peptic ulcer disease, cardiovascular disease, renal insufficiency, and history of gastrointestinal bleeding, according to the MMWR Recommendations and Reports 8, 9

Inappropriate Medications

• The Centers for Disease Control and Prevention advises against prescribing opioids for dysmenorrhea, as they are not more effective than NSAIDs for this condition and carry significant risks of dependence, adverse effects, and long-term use 8, 9

Patient Counseling

• The MMWR Recommendations and Reports suggests prescribing NSAIDs without counseling about gastrointestinal protection in high-risk patients, such as older adults, those with cardiovascular or GI comorbidities, is a common pitfall to avoid 8, 9